Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II.
暂无分享,去创建一个
[1] D. Johns,et al. Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice , 2001, Circulation research.
[2] O. Carretero,et al. Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. , 2000, American journal of physiology. Heart and circulatory physiology.
[3] C. Epstein,et al. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. , 2000, Free radical biology & medicine.
[4] C. Epstein,et al. Role of superoxide in hemorrhagic shock-induced P-selectin expression. , 2000, American journal of physiology. Heart and circulatory physiology.
[5] N. Vaziri,et al. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. , 2000, Hypertension.
[6] B. Giasson,et al. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. , 2000, The Journal of biological chemistry.
[7] M. Bachschmid,et al. Hypoxia–Reoxygenation Triggers Coronary Vasospasm in Isolated Bovine Coronary Arteries via Tyrosine Nitration of Prostacyclin Synthase , 1999, The Journal of experimental medicine.
[8] R. Cohen,et al. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. , 1999, Hypertension.
[9] D. Harrison,et al. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.
[10] C. Wilcox,et al. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. , 1999, Hypertension.
[11] W R Taylor,et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. , 1998, Hypertension.
[12] S. Chanock,et al. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. , 1998, Hypertension.
[13] C. Epstein,et al. Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice , 1998, Neurobiology of Aging.
[14] W. Welch,et al. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. , 1998, Hypertension.
[15] K. Murayama,et al. Inactivation of Human Manganese-superoxide Dismutase by Peroxynitrite Is Caused by Exclusive Nitration of Tyrosine 34 to 3-Nitrotyrosine* , 1998, The Journal of Biological Chemistry.
[16] P. Brecher,et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. , 1998, Circulation research.
[17] J. Zweier,et al. Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.
[18] G. Callis,et al. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Schmid-Schönbein,et al. Oxidative stress in the Dahl hypertensive rat. , 1997, Hypertension.
[20] M. Omata,et al. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. , 1997, American journal of hypertension.
[21] S. Rajagopalan,et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. , 1997, Circulation.
[22] S. Rajagopalan,et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. , 1997, Circulation research.
[23] H. Gavras,et al. Models of experimental hypertension in mice. , 1996, Hypertension.
[24] M. Ushio-Fukai,et al. p22phox Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.
[25] A. Chobanian,et al. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. , 1996, Hypertension.
[26] E. Frohlich. Intervention trials: concerns and publishing pitfalls. , 1996, Hypertension.
[27] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[28] T. Lüscher,et al. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. , 1996, Hypertension.
[29] J. Beckman,et al. The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. , 1996, Advances in experimental medicine and biology.
[30] M. Moskowitz,et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.
[31] J. Morrow,et al. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. , 1995, Circulation research.
[32] C. Epstein,et al. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] R W Alexander,et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.
[34] R. Tabach,et al. Supersensitivity to morphine of the transmurally stimulated vas deferens isolated from ethanol-pretreated mice. , 1992, European journal of pharmacology.
[35] S. Moncada,et al. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. , 1992, European journal of pharmacology.
[36] C. Epstein,et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Sasaki,et al. Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Mulvany,et al. Angiotensin II Causes Vascular Hypertrophy in Part by a Non‐pressor Mechanism , 1991, Hypertension.
[39] S. Moncada,et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.
[40] M. Lovett,et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Cox,et al. Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. , 1980, Proceedings of the National Academy of Sciences of the United States of America.